✦ LIBER ✦

GM-CSF secreting leukemia cell vaccinations after allogeneic non-myeloablative peripheral blood stem cell transplantation in patients with advanced myelodysplastic syndrome or refractory acute myeloid leukemia

✍ Scribed by V.T. Ho; G. Dranoff; M. Pasek; R. MacDonell; C. Cutler; S.J. Lee; E.P. Alyea; J.H. Antin; R.J. Soiffer

Book ID: 116278503
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 67 KB
Volume: 12
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2005.11.057

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

59: GM-CSF secreting leukemia cell vacci

59: GM-CSF secreting leukemia cell vaccinations after allogeneic reduced-intensity peripheral blood stem cell transplantation (SCT) for advanced myelodysplastic syndrome (MDS) or refractory acute myeloid leukemia (AML)

✍ V.T. Ho; G. Dranoff; H. Kim; M. Pasek; C. Cutler; J. Koreth; E.P. Alyea; J.H. An 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Prognostic factors for patients with acu

Prognostic factors for patients with acute myeloid leukaemia or high-risk myelodysplastic syndromes undergoing myeloablative or non-myeloablative allogeneic blood stem cell transplantation

✍ Thorsten Graef; Matthias Vaupel; Roland Fenk; Leilani Ruf; Fabian Zohren; Ulrich 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 1 views

## Abstract In this uni‐centre retrospective study, we studied 120 adults with acute myeloid leukaemia (AML) (__n__ = 88) and myelodysplastic syndrome (MDS) (__n__ = 32) who received first allogeneic HSCT to determine prognostic factors which are correlated with the outcome after myeloablative (MA)

Allogeneic stem cell transplantation aft

Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia

✍ N. Kröger; M. Bornhäuser; G. Ehninger; R. Schwerdtfeger; H. Biersack; H. G. Saye 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 201 KB

Leukemia lineage-specific chimerism anal

Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic stem cell transplantation

✍ Mattsson, J; Uzunel, M; Tammik, L; Aschan, J; Ringdén, O 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 237 KB

Time to engraftment following allogeneic

Time to engraftment following allogeneic stem cell transplantation is significantly longer in patients with myelodysplastic syndrome than with acute myeloid leukemia

✍ Bitan, M; Or, R; Shapira, M Y; Resnick, I B; Gesundheit, B; Ackerstein, A; Samue 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 196 KB

Cytoreductive treatment with clofarabine

Cytoreductive treatment with clofarabine/ara-C combined with reduced-intensity conditioning and allogeneic stem cell transplantation in patients with high-risk, relapsed, or refractory acute myeloid leukemia and advanced myelodysplastic syndrome

✍ Stefanie Buchholz; Elke Dammann; Michael Stadler; Juergen Krauter; Gernot Beutel 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB